Increasing Awareness, Care and Treatment for CAPS:
NOMID/CINCA, MWS, FCAS and other autoinflammatory diseases.
View the CAPS Guidebook
Donate & Support
Other Autoinflammatory Syndromes
Blau (NOD2) (PGA)
Current Clinical trials for CAPS
Clinical Trials for patients with Cryopyrin-Associated Periodic Syndromes
Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease
Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease
Studies of the Natural History and Pathogenesis and Outcome of Neonatal Onset Multisystem Inflammatory Disease (NOMID/CAPS, DIRA, CRMO, Still's Disease, Behcet's Disease, and Other Undifferentiated Autoinflammatory Diseases)
Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients (B-Confident)
Pathogenesis of Physical Induced Urticarial Syndromes (includes FCAS)
The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada (not yet recruiting)
CAPS Clinical Trial with Ilaris in Japan
Japanese CAPS patients over the age of 2 years can enroll in this study with the new medication Ilaris.
A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease (not yet recruiting)
Search for more clinical trials at
Copyright © 2013 NOMID Alliance. All rights reserved.